Almost 50 years ago scientists discovered that tranexamic acid (TxA) causes an inhibition of plasminogen to the active form or plasmin. As a result fibrinolysis and clot breakdown was inhibited thus leading to a greater control over the loss of blood. Originally, TxA was the treatment of choice  for patients with hemophilia as well as to decrease...Read More